Skip to content
Social Garden Enschede

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Package Because of Information Fears

Medical funding illustration
The proposed American funding was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial American healthcare agreement worth $367m (272 million pounds) over five years over Washington's request for confidential data.

The decision was revealed after a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "lopsided".

A government representative later explained that the US was requesting genetic material for research and commercial gain while refused to share the benefits from future vaccines.

"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged continued talks to reach a deal suitable to both sides so the nation's vital HIV programme can be sustained.

Wider Implications

This rejection comes after a similar case in Kenya, where a high court blocked a similar deal with the US after legal challenges were raised about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.

According to statements, 16 African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.

Details of the Declined Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data for a long time, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.

"In essence, our nation would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our citizens should a future pandemic emerge."

Sovereignty and International Frameworks

He also noted that the American exit from the global health body and its pursuit of bilateral deals were undermining frameworks previously set up through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.

"This mechanism is intended to ensure that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our US partners on how subsequent co-operation could be arranged in a way that honours the sovereignty and dignity of both nations."

Health Experts Reaction

A leading public health body stated it understood the government's concerns, but suggested that negotiations need to persist considering much of the nation's Aids initiatives depended on international support.

"If specific concerns exist, such as those involving data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group added.

This impasse highlights the ongoing tensions between receiving vital foreign assistance and protecting national sovereignty in an ever more data-driven world.

The writer

Penny Armstrong

Lena is een enthousiaste tuinierder en sociaal ondernemer, met een passie voor duurzaamheid en gemeenschapsopbouw.

Social Garden Enschede

Type to search articles.